Dimitris Voliotis

Business address
C/O Zentalis Pharmaceuticals, Inc., 530 Seventh Avenue, Suite 2201, New York, NY, 10018
Top holdings (ownership)
ZNTL
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Dimitris Voliotis has filed 4 SEC EDGAR filings since 03 Apr 2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 14 Feb 2022 10 Feb 2022 001-39263
4 Open Document Open Filing FORM 4 20 Jan 2022 18 Jan 2022 001-39263
4 Open Document Open Filing FORM 4 16 Feb 2021 11 Feb 2021 001-39263
3 Open Document Open Filing FORM 3 SUBMISSION 03 Apr 2020 03 Apr 2020 001-39263